Assignee
SHENGKE PHARMACEUTICALS JIANGSU LTD
CN·4 granted patents·3 pending applications·7 citations·filing 2018–2022
Top patents by PatentIndex Score
7 records- 0188US11993604B2Substituted pyrazolo[4,3-H]quinazolines as protein kinase inhibitorsSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2022·Granted May 28, 2024·2 cites·32 claims
- 0283US11319323B2Substituted pyrazolo[4,3-H]quinazolines as protein kinase inhibitorsSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2018·Granted May 3, 2022·3 cites·19 claims
- 0376US11091485B2Imidazo[1′,2′:1,6]pyrido[2,3-d]pyrimidine compound as protein kinase inhibitorSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2018·Granted Aug 17, 2021·2 cites·18 claims
- 0457US2025026719A1Novel compounds as inhibitors of pcsk9SHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2022·Application pending·0 cites
- 0552US2023312583A11h-imidazo [4,5-h] quinazoline compound as novel selective flt3 inhibitorsSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2021·Application pending·0 cites
- 0652US2023122967A1Novel compounds as inhibitors of pcsk9SHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2021·Application pending·0 cites
- 0738US12428423B21H-imidazo[4,5-h]quinazoline compound as protein kinase inhibitorSHENGKE PHARMACEUTICALS JIANGSU LTD·Filed 2018·Granted Sep 30, 2025·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when SHENGKE PHARMACEUTICALS JIANGSU LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →